Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ki Tua Fund is a venture capital firm founded to collaborate with innovative founders and start-ups, particularly in health-related sectors. The firm operates globally, with a focus on North America and Europe, and has a portfolio of nine companies. Inspired by the Fonterra Group, Ki Tua Fund emphasizes agility and responsiveness in its investment approach.
Ki Tua Fund invests in pre-seed to Series A stages, providing flexible capital to start-ups developing solutions in healthcare, biotech, climate, and agtech. The firm prioritizes a founder-first ethos, which may include follow-on funding and lead investments. Their investment strategy connects founders with a broad commercial capability and investment ecosystem.
Notable portfolio companies include BioLumic, an agricultural biotechnology firm; Cyclarity Therapeutics, focused on synthetic molecules for age-related diseases; and Kanvas Biosciences, which develops microbiome therapeutics. Other investments include Nimble Science, Pendulum Therapeutics, Prolific Machines, Sun Genomics (Floré), Swan Genomics, and Tune Therapeutics.
Submit your pitch through their form at kituafund.com or email connect@kituafund.com with your deck.
Yes, Ki Tua Fund is open to leading investment rounds, particularly when partnering with founders who align with their mission.
The firm is supportive of follow-on investments, ensuring that they can continue to back their portfolio companies as they grow.
Specific details about the fund size are not disclosed, but the firm focuses on providing flexible capital to its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.